Search results
Results From The WOW.Com Content Network
The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.
August 18, 2024 at 9:24 AM. Bristol Myers Squibb (NYSE: BMY) has had a rough past five years. Its shares are barely in the green, its financial results have been unimpressive, and it has faced ...
Deucravacitinib. Deucravacitinib, sold under the brand name Sotyktu, is a medication used for the treatment of moderate-to-severe plaque psoriasis. [ 7] It is a tyrosine kinase 2 (TYK2) inhibitor and it is taken by mouth. [ 7] It was developed by Bristol Myers Squibb. [ 10]
By This, May, 15, story and has. (Reuters) - The U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi for the treatment of adults ...
Show comments. (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer in patients with a specific gene mutation ...
Retrieved from "https://en.wikipedia.org/w/index.php?title=Bristol-Myers_Squibb_Company&oldid=971830359"
The U.S. Food and Drug Administration on Thursday expanded the use of Bristol Myers Squibb's cell therapy, Breyanzi, for a type of slow-growing blood cancer, marking the third approval for the ...
Pages in category "Drugs developed by Bristol Myers Squibb" The following 66 pages are in this category, out of 66 total. This list may not reflect recent changes .